Close

Resources and Information about the Zika Virus

Zika virus, transmitted to people primarily through the bite of Aedes species mosquito (A. aegypti and A. albopictus), is a member of the Flaviviridae family, which includes medically important human pathogens such as dengue fever, yellow fever, Japanese encephalitis, tick-borne encephalitis, and West Nile viruses. The Centers for Disease Control and Prevention (CDC) has concluded that the Zika virus causes severe birth defects, particularly microcephaly, a congenital condition marked by an abnormally small head and incomplete brain development. It has also been linked to Guillain-Barre syndrome (GBS), a rare autoimmune disorder that can cause paralysis.

Other than mosquito control, no approved preventive or therapeutic products are currently available to fight Zika infections. In June 2016, the first potential vaccine for Zika received approval from the FDA to begin Phase I clinical trials. Public health officials recommend avoiding exposure to Zika, delaying pregnancy, and following basic supportive care after infection. Additional information may be found below.

Zika Prevention & Guidance

Zika Vaccines & Therapeutics R&D

Zika Vector Control - Genetically Modified Mosquitos

Zika Research

Zika in the News

2016

2017

BIOtechNOW Blog Posts